These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17880000)

  • 61. Mass spectrometry and serum pattern profiling for analyzing the individual risk for endometriosis: promising insights?
    Wölfler MM; Schwamborn K; Otten D; Hornung D; Liu H; Rath W
    Fertil Steril; 2009 Jun; 91(6):2331-7. PubMed ID: 18555242
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease.
    Fujiwaki T; Tasaka M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):170-6. PubMed ID: 18502707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls.
    Barrett JH; Cairns DA
    Stat Appl Genet Mol Biol; 2008; 7(2):Article4. PubMed ID: 18312218
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
    van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
    Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Screen anti-influenza virus serum marker of Lonicera japonica by proteomics technology].
    Zhang H; Song J; Shi J
    Zhongguo Zhong Yao Za Zhi; 2011 Apr; 36(8):1071-4. PubMed ID: 21809588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elastic net-based framework for imaging mass spectrometry data biomarker selection and classification.
    Zhang FZ; Hong D
    Stat Med; 2011 Mar; 30(7):753-68. PubMed ID: 21394751
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A mixture model approach to the tests of concordance and discordance between two large-scale experiments with two-sample groups.
    Lai Y; Adam BL; Podolsky R; She JX
    Bioinformatics; 2007 May; 23(10):1243-50. PubMed ID: 17384018
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma.
    Donahue MP; Rose K; Hochstrasser D; Vonderscher J; Grass P; Chibout SD; Nelson CL; Sinnaeve P; Goldschmidt-Clermont PJ; Granger CB
    Am Heart J; 2006 Sep; 152(3):478-85. PubMed ID: 16923417
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biomarker clustering to address correlations in proteomic data.
    Carlson SM; Najmi A; Cohen HJ
    Proteomics; 2007 Apr; 7(7):1037-46. PubMed ID: 17390293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma peptidome: A new approach for assessing thrombotic risk?
    Scully MF
    Thromb Haemost; 2006 Dec; 96(6):697. PubMed ID: 17139360
    [No Abstract]   [Full Text] [Related]  

  • 71. [The possibility of increasing the precision of biochemical diagnostics of Gaucher disease].
    Horovenko NH; Drozdova VD; Nedoboĭ AM; Ol'khovych NV; Pichkur NO; Tsyhankova MA; Radzikhovs'ka OV
    Tsitol Genet; 2006; 40(3):67-71. PubMed ID: 16933855
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Promise of multiphoton detection in discovery and diagnostic proteomics.
    Godovac-Zimmermann J; Mulvey C; Konstantoulaki M; Sainsbury R; Brown LR
    Expert Rev Proteomics; 2007 Apr; 4(2):161-73. PubMed ID: 17425453
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protocols for disease classification from mass spectrometry data.
    Wagner M; Naik D; Pothen A
    Proteomics; 2003 Sep; 3(9):1692-8. PubMed ID: 12973727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential protein expression patterns obtained by mass spectrometry can aid in the diagnosis of Hodgkin's disease.
    Carvalho PC; Carvalho Mda G; Degrave W; Lilla S; De Nucci G; Fonseca R; Spector N; Musacchio J; Domont GB
    J Exp Ther Oncol; 2007; 6(2):137-45. PubMed ID: 17407972
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature.
    Roesli C; Neri D; Rybak JN
    Nat Protoc; 2006; 1(1):192-9. PubMed ID: 17406232
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma.
    Lin Q; Peng Q; Yao F; Pan XF; Xiong LW; Wang Y; Geng JF; Feng JX; Han BH; Bao GL; Yang Y; Wang X; Jin L; Guo W; Wang JC
    PLoS One; 2012; 7(3):e34457. PubMed ID: 22461913
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry data.
    Conrad TO; Genzel M; Cvetkovic N; Wulkow N; Leichtle A; Vybiral J; Kutyniok G; Schütte C
    BMC Bioinformatics; 2017 Mar; 18(1):160. PubMed ID: 28274197
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical model.
    Patil ST; Higgs RE; Brandt JE; Knierman MD; Gelfanova V; Butler JP; Downing AM; Dorocke J; Dean RA; Potter WZ; Michelson D; Pan AX; Jhee SS; Hale JE
    J Proteome Res; 2007 Mar; 6(3):955-66. PubMed ID: 17243662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel wavelet-based thresholding method for the pre-processing of mass spectrometry data that accounts for heterogeneous noise.
    Kwon D; Vannucci M; Song JJ; Jeong J; Pfeiffer RM
    Proteomics; 2008 Aug; 8(15):3019-29. PubMed ID: 18615428
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease.
    Vissers JP; Langridge JI; Aerts JM
    Mol Cell Proteomics; 2007 May; 6(5):755-66. PubMed ID: 17293593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.